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Background: Health checks are becomingmore available in the community, with the intention of disease
detection and prevention in asymptomatic people. This article summarises ﬁndings in an Australian
adult sample from a health check conducted at the National Institute of Integrative Medicine (NIIM).
There has been controversy regarding reference ranges and what constitutes optimal and standard
reference ranges. Biomarkers were compared with standard reference ranges, and with optimal health
reference ranges.
Methods and results: A total of 139 participants voluntarily undertook the NIIM Health Check across a
4 year period. Participants underwent a full day of medical examinations, including liver and kidney
function, thyroid, full blood count, glucose, vitamin andmineral tests. Suboptimal values were evident in
a large portion of participants in vitamin D, vitamin B12, homocysteine, and iodine levels. Variables such
as age, gender, body mass index (BMI) and season were important covariates.
Conclusion: The sub-optimal levels in vitamin D, vitamin B12, sub-standard levels in iodine, and
excessive homocysteine, were consistent with previous population studies and are associated with a
number of preventable diseases such as dementia, hypertension, cancer and thyroid disease. Our
analysis highlights the importance to screen for biomarkers prone to deﬁciencies in Australia.
 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).What is already known about the topic? H(K
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4.ealth checks are becoming more available in the community,
with the intention of disease detection and prevention in
asymptomatic people. Sub-optimal levels of vitamins and minerals can lead to long
term health problems.
What this paper adds? Sub-optimal levels in vitamin D, vitamin B12, sub-standard
levels in iodine, and excessive homocysteine, were evident in a
large portion of asymptomatic participants. Sub-optimal levels in vital biomarkers are associated with a
number of preventable diseases such as dementia, hypertension,
cancer and thyroid disease. Our article highlights the importance to screen for biomarkers
prone to deﬁciencies in Australia.* Corresponding author.
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0/).1. Introduction
The recent National Health Survey indicates an all-time high
prevalence of chronic diseases among Australians, including
cancer, diabetes, cardiovascular disease, long-term mental or
behavioural conditions and asthma [1,2]. Almost all Australians
(99%) aged 15 and over have at least one risk factor for poorer
health such as high blood pressure or vitamin deﬁciency due to
poor nutrition, and about 1 in 7 people have ﬁve or more risk
factors [3]. Encouraged by these statistics, we have initiated a
health check programme that evaluates both current and potential
matters of health and offers follow-up advice.
Medical screening has a long history [4]. The World Health
Organization (WHO) has encouraged a holistic view of health by
deﬁning it as ‘a state of complete physical, mental and social well-
being and not merely the absence of disease or inﬁrmity’
[5]. Screening tests and examinations, including comprehensive
health checks can help with detection and prevention of diseases.
Health checks have become a common part of hospitals,
insurance companies, schools and workplaces. Notably, the
Victorian government implemented the Work Health programme
which conducted approximately 800,000 workplace health checks
with the intention of promoting a healthier workforce. However,e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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routinely assessed in general practice, which we investigated in
this study [6].
The health check data used for this analysis was acquired from
the National Institute of Integrative Medicine, ‘The NIIM Health
Check’, collected over a four year period. The analysis examined
levels required for optimal health rather than minimal levels to
avoid disease. For a number of biomarkers such as vitamin D,
standard reference ranges are below the optimal ranges that are
needed for optimal health. Many vitamin D experts advocate
maintaining 25(OH) D levels at>75 nmol/L (used in the study) up
to as high as 80 nmol/ml or 200 nmol/L [7–9] whereas the
standard reference range is considered >50 nmol/L. Optimal
vitamin D levels (>75 nmo/L) have been associated with maxi-
mum mineral bone density, increased intestinal calcium absorp-
tion, decreased risk of osteoporosis and risk of fracture, higher
serum phosphorus levels, increased performance speed and
proximal muscle strength, and a signiﬁcant decrease in the
likelihood of chronic diseases such as cancers, auto immune
disease, osteoarthritis and diabetes [7–9]. The vitamin B12
standard reference range is 200–700 pg/mlwhereas the proposed
optimal range is 500–1300 pg/ml [10]. Higher vitamin B12 ranges
have been associated with increased cognitive function, and
reﬂexes, decreased brain atrophy, confusion, weakness and
depression [10]. Additionally, many experts suggest that the
optimal health range for homocysteine is <7 mmol/L and the
standard reference range is 5.0–12 mmol/L, with the optimal
range showing a signiﬁcant association with a lower likelihood of
stroke, atherosclerosis and improved overall cardiovascular
function [11].
The aim of the present study was to determine whether a
sample of health check participants would provide results
consistent with previous population literature regarding a number
of vital biomarkers.
2. Methods
The data was obtained from a de-identiﬁed cohort of
asymptomatic individuals in the National Institute of Integrative
Medicine’s ‘NIIM Health Check’, between November 2010 and
December 2014. The NIIMHealth Check includes a broad spectrum
of innovative medical testing considered one of the most
comprehensive integrative health checks in Australia [12].
Participants responded to an advertisement on the NIIM
website and provided consent for their de-identiﬁed data to be
used in this study. The NIIM Health Check receives mainly
participants with no symptoms who participate purely for a
preventative purpose. Participants can choose from several Health
Check packages featuring different suites of tests and costs.
Therefore not all participants necessarily undertake all tests. The
NIIM Health Check payments are not covered by the clinic or
Medicare. Costs are typically paid directly by the patient, with
some participants being sponsored by their workplace. The
majority of NIIM Health Check participants come from higher
socioeconomic backgrounds. However a number of participants
earning an average wage participate via an instalment plan.
Participants consented to allow for the collection and analysis of
completely anonymous data. Only those consenting were eligible
to have such anonymous data collated for research purposes.
Participants were considered eligible if they were capable of
attending three appointments across one-month duration, con-
sisting of an initial 5-h screening appointment a 1.5 h medical
imaging appointment, and a 2 h ﬁnal reviewing consultationwith a
General Practitioner (GP) practicing integrative medicine (the
combination of evidence-based complementary and conventional
medicine).Socio-demographic data was obtained from a standardised
online health questionnaire routinely administered to participants
prior to their initial appointment. The ﬁrst appointment involved
comprehensive pathology testing. The ﬁnal appointment took
place 4 weeks following the ﬁrst appointment and included a
consultation with an integrative GP, where all reports and test
results were discussed. Following the NIIM Health Check,
treatment strategies for any abnormalities were discussed, which
included behavioural factors such as diet, sleep, exercise, sun
exposure, as well as supplementation and/ormedication. The NIIM
Health Check pathology results are presented here. Pathology tests
included liver and kidney function, thyroid, full blood count,
glucose, vitamin and mineral tests.
2.1. Statistical analyses
Descriptive analyses were undertaken for all blood tests and
were compared to population reference ranges (Melbourne
Pathology) and optimal ranges [7,8,10,25,26,37]. Data was sub-
grouped by age, gender, BMI and season. An analysis of variance
(ANOVA) was used to establish signiﬁcant differences. All analyses
were conducted with IBM SPSS version 22.
3. Results
A total of 139 participants undertook the NIIM Health Check.
Not all biomarkers were measured for all participants, depending
on patient requests (Table 1). Extremely high outlier values, due to
supplementation, were excluded. Mean age of the overall study
population was 48.8 years (range 28–82 years) with an even
gender balance (52.5%males). The majority of participants were of
a higher socio-economic status with higher education (80%),
mainly non-smokers (90%), and asymptomatic.
Mean blood test results at baseline and the proportion of
participants that had levels in the standard reference range are
summarised in Table 1. Signiﬁcant differences between genders
were found in a number of blood tests, such as ferritin (p < 0.001),
transferrin (p = 0.001), saturated transferrin (p = 0.003), haemo-
globin (p < 0.001), red blood cell (p < 0.001), platelets (p = 0.002),
erythrocyte sedimentation rate (p = 0.009), and creatinine
(p < 0.001) (Table 1). A majority of participants were in the
standard reference range for each biomarker, but close to half of
the female sample was below the red blood cell and creatinine
reference range (56.4% and 69.6% respectively). Standard reference
ranges are closely linked to optimal health and minimal risk of
diseases. However, for a number of biomarkers, standard reference
values were below levels considered to achieve optimal health
(Table 2).
In our population, mean vitamin D, vitamin B12, homocysteine,
and iodine levels were below their optimal levels (Fig. 1B) even
though a majority of participants were within the standard
reference range for each of these biomarkers (Fig. 1A).We explored
these further by BMI and age categories (Table 2). Mean vitamin D
serum level was 68.64 nmol/L, below the optimal level of
>75 nmol/L. A trend revealed that mean vitamin D levels were
higher in males than in females (mean difference = 11 nmol/
L  8.9, p = 0.16) in the youngest age category (39 years), compared
to a mean difference of 2.59 nmol/L (40–59 years, p = 0.68) and
4.9 nmol/L (60 years, p = 0.55). BMI was inversely correlated to
vitamin D levels in healthy weight males (80.81 nmol/L) and obese
males (61 nmol/L) (r = 0.25, p = 0.048). Additionally, vitamin D
levels were correlated to seasonal changes in winter months in
Australia (r = 0.24, p = 0.06). There was a borderline signiﬁcant
difference of 11.14 nmol/L between males and females during winter
months (p = 0.056), and a signiﬁcant difference for females between
winter (59.48 nmol/L) and summer (70.3 nmol/L) months (p = 0.037).
Table 1
NIIM Health Check serum tests compared to standard reference levels (n=139).
Biomarkers Sub-group Reference range N % of total N Mean SD % within reference
range
p-value
mean diff m/f
BMI 18.5–24.9kg/m2 119 86 26.9 4.7 36.1
SBP <140mmHg 115 83 123.3 15.3 84.3
DBP <90mmHg 115 83 74.6 10.1 91.3
Glucose 3.6–6mmol/L 115 83 4.9 1.7 93.9
TSH 0.5–5.5mU/L 81 58 2 2.3 97.5
T4 11.0–21pmol/L 57 41 15.9 6.2 89.5
T3 3.2–6.4pmol/L 57 41 15.9 6.2 91.2
Folate >800nmol/L 83 60 2013.5 604.2 96.4
CRP <5mg/L 115 83 1.9 3.1 92.2
Cortisol 170–550nmol/L 58 42 353.6 166.9 91.4
Iron 5–30mmol/L 112 81 18.3 6.5 94.6
Ferritin 30–500ng/ml 118 85 163.8 118.0 91.5
m/f 61/57 44/41 226/97 115/78 95.1/87 <0.01
Transferrin 2–3.2 g/L 115 83 2.6 0.4 90.4
m/f 58/57 42/41 2.5/2.8 0.4 93.1/88 0.001
Transferrin S 10–45% 114 82 28.4 11.4 91.2
m/f 57/57 41/41 32/25 12/10 86/97 0.003
Haemoglobin 130–180g/L 115 83 143 12.1 84.3
m/f 59/56 42/40 151/135 11/7 95/73 <0.01
RBC 4.3–5.81012 L1 114 82 4.6 0.7 74.6
m/f 59/55 42/40 4.9/4.4 0.7/0.6 95/73 <0.01
MCV 80–100 fL 112 81 90.3 9.4 95.5
Platelets 150–450109 L–1 116 83 227.5 51.5 95.7
m/f 59/57 42/41 213/243 50/49 92/100 0.002
White blood cells 4.0–11109 L1 113 81 6.3 4.2 91.2
Neutrophils 2–7.5109 L1 115 83 3.4 1.2 95.7
Lymphocytes 1.0–4109 L1 115 83 1.7 0.5 100
Monocytes 0–1.0109 L1 115 83 0.3 0.12 100
Eosinophil 0–0.5109 L1 113 81 0.1 0.2 98.2
ESR 2.0–14mm/h 114 82 6.9 6.4 78.1
m/f 59/55 42/40 5.5/8.6 5.7/6.7 76.3/80 0.009
Sodium 135–145mmol/L 114 82 140.3 2.1 100
Potassium 3.5–5.5mmol/L 114 82 4.2 0.3 100
Chloride 95–110mmol/L 113 81 102.3 2.7 99.1
Bicarbonate 20–32mmol/L 114 82 27.5 2.6 100
Urea 3.5–8.5mmol/L 110 79 5.1 1.7 86.4
Creatinine 60–110mmol/L 111 80 76.8 19.6 81.1
m/f 55/56 40/40 88/66 20/12 93/70 <0.001
eGFR >60 rate 101 73 84.4 14.9 97.0
ALP 35–110U/L 109 78 61.7 20.5 91.7
GGT 5–50U/L 110 79 22.6 14.1 94.5
CoQ10 709–1392mmol/L 91 66 998.2 534.0 72.5
m/f 51/40 37/29 1028/961 620/418 73/73 0.04
Standard Melbourne Pathology reference ranges.
Abbreviations: SD= standard deviation, mmHg=millimetre of mercury, mU/L =milliunits per litre, pmol/L =picomole per litre, N=All participants tested for respective
biomarker, nmol/L =nanomole per litre, mg/L =milligramme per litre, mmol/L=micromoles per litre, ng/L =nanogram per litre, mmol/L =millimoles per litre, g/L = gram per
litre, fL = femtolitres (1019), ng/ml=nanogram per millilitre, mm/h=millilitre per hour, SBP= systolic blood pressure, DBP=diastolic blood pressure.
N. Travica et al. / Advances in Integrative Medicine 2 (2015) 135–140 137The mean iodine level was 73.8 mg/L, below the optimal range
of 100–199mg/L, with a signiﬁcant difference between males and
females (p = 0.042). On average, iodine levels were highest in the
40–59 year age group, but lowest in the over 60 year age group.
BMI levels only slightly inﬂuenced iodine levels. Average iodine
levels increased with BMI, approaching optimal levels in the
overweight and obese subgroups (Table 2). Further analyses
revealed a strong signiﬁcant positive correlation between female
iodine levels and triiodothyronine (T3) (r = 0.50, p = 0.009).
A negative correlation was found between homocysteine levels
and folate levels (r = 0.29, p = 0.08) or vitamin B12 levels
(r = 0.32, p = 0.03). The mean vitamin B12 level was 449.13 pg/
ml below the optimal range of 500–1300 pg/ml. Vitamin B12 levels
remained consistent across all age subgroups for each gender. The
reported median was 43,400 pg/ml and was positively skewed
(skewness of 1.72). BMI did not appear to have a clear effect
although the proportion of participants in the optimal range
dropped to as low as 11% as BMI levels increased (Table 2).
The mean homocysteine level was 9.39mmol/L, 34.33% above
the optimum level (7mmol/L). Males had a signiﬁcantly higher
homocysteine level than females in the <39 years age category(p = 0.05). Homocysteine gradually increased by age in females (by
2.32mmol/L, <39 years compared to subgroup to >60 age
subgroup, p = 0.08).
4. Discussion
The study summarised test results of the NIIM Health Check
revealing suboptimal levels in vital biomarkers, including vitamin
D, iodine, vitamin B12, and homocysteine.
Suboptimal vitamin D levels were present in every age group
except for young males (<39 years). Body mass index was
inversely correlated to vitamin D levels with a signiﬁcant
difference between healthy weight males and obese males.
Moreover, vitamin D levels were correlated to seasonal changes
particularly in signiﬁcant difference females.
The deﬁnition of what constitutes optimal vitamin D levels has
varied, and cut-off points have not been developed by a scientiﬁc
consensus process. It has been proposed that 25(OH) vitamin D
levels at >75 nmol/L (used in the study) and even as high as
200 nmol/L are associated with optimal health [7–9]. This higher
value is based on the level below which parathyroid hormone
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Fig. 1. Proportion of participants with sub-standard (A) or non-optimal (B) levels of
vital biomarkers. Iodine: optimal/standard reference range = 100–199 mg/L;
vitamin D: standard reference range 50 nmol/L; optimal range 75 nmol/L;
vitamin B12: standard reference range = 200–700 pg/ml; optimal range = 500–
1300 pg/ml; homocysteine: standard reference range = 5.0–12 mmol/L; optimal
range = 7 mmol/L. Abbreviations: nmol/L = nanomoles/L; mg/L = microgram per
litre; pg/ml = picogram per millilitre; mmol/L = micromoles per litre.
N. Travica et al. / Advances in Integrat ve Medicine 2 (2015) 135–140138concentrations begin to rise and the risk of fractures and chronic
diseases increases [13]. Rather, higher vitamin D levels (>75 nmol/
L) have been associated with decreased risk of osteoporosis,
cancers, autoimmune disease, osteoarthritis and diabetes [7–9].
The main cause of suboptimal vitamin D levels in Australians is
insufﬁcient exposure to sunlight [14–16], the time of day exposed
(early morning sun is weaker than during mid-afternoon), lower
than recommended vitamin D intake, genetic factors including
kidneys inadequately converting the oral 25(OH) D to its active
form, or low absorption of vitamin D in the digestive tract. Vitamin
D deﬁcient diets are those with milk allergy, lactose intolerance,
ovo-vegetarianism, and veganism [17].
Vitamin D deﬁciency is more common in winter, and in females
compared to males in line with the variability found amongst
females in our study [18]. Low vitamin D levels often lead to
seasonal affective disorder and low mood [19]. Vitamin D
deﬁciency has also been linked to bone and muscle weakness,
increased risk of cardiovascular disease and cognitive impairments
[7].
Our ﬁndings are consistent with Australian population studies,
whereby an estimated vitamin D deﬁciency is present in 15–52% of
older Australians [20,21], due to younger individuals <50 years
being more capable of storing vitamin D for 6 months during
winter [22]. This age difference is also partly explained by age-
related thinning of the skin and a reduction in synthesising vitamin
D efﬁciently [23,24].
Higher BMIwas associatedwith lower vitamin D levels which is
likely linked with a sedentary lifestyle and reduced outdoor
activities [25,26]. Obese individuals may need larger than usual
intakes of vitamin D to achieve optimal 25(OH) D levels compared
N. Travica et al. / Advances in Integrative Medicine 2 (2015) 135–140 139to those with ideal BMI [27]. Obesity does not affect the skin’s
capacity to synthesise vitamin D, but greater amounts of
subcutaneous fat sequester more of the vitamin and alter its
release into the circulation [27].
Secondly, females demonstrated signiﬁcantly lower iodine
levels than our male sample. Age and BMI were inversely
correlated with iodine levels. Optimal iodine level recommenda-
tions range from 100 to 199mg/L [28,29]. Iodine plays a central
role in healthy function of the thyroid gland. Iodine deﬁciency has
been linked to preventablemental retardationworldwide [28], and
thyroid enlargement (goitre).
Iodine deﬁciency in Australia is associated with the poor iodine
levels in the soil, leading to low levels in foods and hence low
dietary intakes [30]. Iodine is found in a range of foods, dairy
products, seafood, seaweed (kelp), eggs, bread, some vegetables
and iodised salt [31]. Our resultsmay be due to low consumption of
iodine-rich foods, especially within females. Fluorinated water
consumption, lack of iodide supplementation in the food and
agricultural industry, are further explanations for iodine depletion
[30].
Our sample of women had signiﬁcantly lower iodine levels
than men, and deﬁciency decreased with age, consistent with
population studies [32,33]. The National Health Measures
Survey (2011–2012), also indicated that iodine levels tended
to increase with increasing BMI, also consistent with our results.
Furthermore, the negative correlation between triiodothyronine
(T3) levels and iodine levels found in female sample is indicative
of a deﬁcient iodine level, consistent with early signs of
hypothyroidism.
Thirdly, vitamin B12 levels were below optimal levels in our
sample, and inversely correlated to BMI, consistent with popula-
tion studies [34,35]. Recommended levels for vitamin B12
deﬁciency vary in different countries. When the serum level drops
below 500 or 550 pg/ml the cerebrospinal ﬂuid level can become
deﬁcient [36]. A lack of vitamin B12 is associated with dementia,
brain atrophy [37], various neurological disorders, neuralgia,
neuritis and bursitis [38,39]. Some experts suggested the current
recommended range of vitamin B12 is too low and that the optimal
range should be at least 500–1300 pg/ml [10]. Brain atrophy,
associated with dementia is reversible with adequate vitamin B12
levels [37,40].
Vegan diets and diets low in vitamin B12 found in red meats,
ﬁsh, dairy and eggs result in diminished stores of vitamin B12
[32,39]. Low levels of acetyl-carnitine and folic acid as well as
antacids & antibiotics chronic overuse may be responsible
[41]. Absorption of vitamin B12 can be compromised by
microwaving food [42].
There was an inverse correlation between low vitamin B12
levels and homocysteine levels. Homocysteine levels below
7mmol/L are ideal, a sharp increase in stroke incidence occurs
when homocysteine levels exceed 11mmol/L [11]. Elevated
homocysteine levels may lead to early heart attack and stroke,
narrowing the carotid artery and Alzheimer’s disease and other
types of dementia [43]. Risk factors for high homocysteine levels
includemale gender, smoking, coffee consumption, increasing age,
high blood pressure, an unfavourable lipid proﬁle, and high
creatinine. Variables such as physical activity, moderate alcohol
consumption, and an adequate folate or vitamin B12 status are
associated with lower homocysteine concentrations [44].
Our study results are in line with similar studies whereby
homocysteine levels in males aged less than 39 years were lower
than in females and increasing with age [45–47]. Changes in renal
function [46] and impaired renalmetabolism of homocysteine play
a role [48], as well as differences in BMI, oestrogen status, vitamin
status, creatinine production, folate, vitamin B12, and vitamin B6
status [49].There were some limitations in the present study. Although
139 participants were recruited across a four year duration, these
participants were mainly from a higher socio-economic ranking
coming to one clinic located in an inner city suburb of Melbourne,
and may not be representative of the general population. A further
limitation was that not all participants chose to do all the tests
assessed in this study reducing the sample sizes for individual
tests.
However, as our participants represent a healthy asymptomatic
sample of the general population, our ﬁndings can provide a guide
to optimising preventative health assessments by incorporating
screening of some vital biomarkers.
To better guide practitioners and patients in determining
individual’s optimal levels, some biomarkers, such as vitamin B12
should be presented in reference ranges by sex and age groups, as
needs vary across the lifespan.
5. Conclusion
Our results are in line with the literature, which indicated that
Australian adults are prone to suboptimal vitamin D and vitamin
B12 levels, sub-standard iodine levels and high homocysteine
levels. Regular monitoring, taking into account age, gender, BMI
and seasonal differences would help prevent associated problems
and illnesses. Health check programmes such as the NIIM Health
Check have the potential in determining signiﬁcant deﬁciencies
and health concerns by a standard suite of simple blood tests.
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